SEC Form D filing

Quince Therapeutics, Inc.

Biotech · Series C · Regulation D 506(b) · CA · Filed June 11, 2026

Offering amount

$186.4M

Exemption

Reg D 506(b)

Issuer state

Filing date

June 11, 2026

Signature date

June 11, 2026

CIK

0001662774

Summary

Auto-generated

Quince Therapeutics, Inc., $186.4M raise, CA-based biotech.

Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Filing history

Quince Therapeutics, Inc. has filed 2 Form D filings totaling $193.8M that FormDFlow has indexed.

June 11, 2026Reg D 506(b)$7.4M

Source

View on SEC EDGAR →Get alerts for filings like this →

FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.